ABV 9 - EU, S.C.Sp is a private equity fund based in Grand Duchy of Luxembourg, Luxembourg. According to its most recent Form D, filed Dec 19, 2025, it has sold $62,000,000 of interests to 2 investors since its first sale in Dec 2024. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Christina Gibbs; ABV 9 Lux GP S.a r.l; Matthijs Haarsma.
- Total raised
- $62,000,000Cumulative sales reported on Form D
- Investors
- 2
- First sale
- Dec 23, 2024
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Christina Gibbs; ABV 9 Lux GP S.a r.l; Matthijs Haarsma
- Latest Form D
- Dec 19, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about ABV 9 - EU, S.C.Sp
What is the minimum investment for ABV 9 - EU, S.C.Sp?
ABV 9 - EU, S.C.Sp's latest Form D, filed Dec 19, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in ABV 9 - EU, S.C.Sp?
ABV 9 - EU, S.C.Sp is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has ABV 9 - EU, S.C.Sp raised?
ABV 9 - EU, S.C.Sp reports $62,000,000 sold from 2 investors on its Form D filed Dec 19, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is ABV 9 - EU, S.C.Sp based?
ABV 9 - EU, S.C.Sp is based in Grand Duchy of Luxembourg, Luxembourg.
When did ABV 9 - EU, S.C.Sp launch?
ABV 9 - EU, S.C.Sp reports its first sale in Dec 2024.
Size compared with every private equity fund
Raised more than 58% of the 585 private equity funds based in Luxembourg, and more than 67% of all 9,142 that report sales.
Other funds with the same team
- Carlyle Europe Partners VI - EU, S.C.Sp.$666M
- Abingworth Bioventures 9 LP$320M
- Carlyle Europe Partners VI, S.C.Sp.$118M
- Carlyle ARE Partners II, L.P.$0
- Abingworth Clinical Co-Development 3 Feeder, L.P.$0
- Carlyle Kernel Partners, L.P.$0
- Carlyle Twilight Partners II, L.P.$0
- Abingworth Clinical Co-Development Fund 3 LP$0
More private equity funds in Grand Duchy of Luxembourg
- Keensight Nova VII SCSp$42.1M
- Global Infrastructure Partners Tonalli Fund, SCSp$1.1B
- Blackstone Private Markets Solutions SCA-SICAV - Blackstone Infrastructure Strategies ELTIF$7.2M
- Blackstone Private Equity Strategies Fund SICAV$209M
- Arrow Real Estate Opportunities II SCSp, SICAV-RAIF$69.8M
- Westwind European Real Estate Partners I SCSp SICAV-RAIF$5.8M